Tag: BioCryst Pharmaceuticals Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to BioCryst Pharmaceuticals Inc.

DAFNA Capital Management LLC Buys Galapagos NV, Cassava Sciences Inc, Dicerna ...

Added to Collection on: 2021-02-16 23:37:30

Tags for this article:

Financial markets
Financial economics
Corporate finance
Stock
Stock market
Dafna
Finance
Dicerna Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc
Immunomedics Inc.
BioCryst Pharmaceuticals Inc.
Kinnate Biopharma Inc.
Fate Therapeutics Inc
Cassava Sciences Inc.
Venus Concept Inc.
Dafna Capital Management Llc
Galapagos NV

Click the tags to see associated articles and topics

View Article Details
Which institution holds the most shares in BioCryst Pharmaceuticals Inc. (BCRX)

Added to Collection on: 2021-03-05 19:18:45

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
BioCryst Pharmaceuticals
Stock
Short
NASDAQ
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs

Added to Collection on: 2021-03-12 12:33:45

Tags for this article:

Companies
Economy of New York City
NASDAQ
Sanofi
Bristol-Myers Squibb
Novavax
EMachines
Cyclacel
Nasdaq, Inc.
Bolt Biotherapeutics, Inc.
BioCryst Pharmaceuticals Inc.
Entera Bio Ltd.
Apyx Medical Corporation
Axonics Modulation Technologies Inc.
AngioDynamics Inc.
AVEO Pharmaceuticals Inc.
bioatla, inc.

Click the tags to see associated articles and topics

View Article Details
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Expected to Post Earnings of -$0.28 Per Share

Added to Collection on: 2021-03-13 10:04:02

Tags for this article:

Financial ratios
BioCryst Pharmaceuticals
Finance
Fundamental analysis
Corporate finance
Companies
Life Sciences
Peramivir
Price?earnings ratio
Earnings per share
ANGI Homeservices
BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
BitMEX Co-Founder Arthur Hayes Offers to Surrender to US Authorities in Hawaii

Added to Collection on: 2021-03-17 10:25:14

Tags for this article:

Companies
Pharmaceutical companies
Life Sciences
Economy of New York City
NASDAQ
AstraZeneca
Johnson & Johnson
Amneal Pharmaceuticals
Genmark Diagnostics Inc
Sotera Health Company
Champions Oncology Inc.
Organogenesis Holdings Inc.
Omnicell Inc.
Moderna
Solid Biosciences
Roche Holding AG
Aerie Pharmaceuticals Inc.
Renalytix AI plc
BioCryst Pharmaceuticals Inc.
Rubius Therapeutics Inc.
IDEAYA Biosciences Inc.
Samples Fulgent Genetics Inc.
Amneal Pharmaceuticals Inc.
Vincerx Pharma Inc.
Gemini Therapeutics Inc.
Silverback Therapeutics Inc.
FULGENT GENETICS
Harvard Bioscience Inc.
Aclaris Therapeutics Inc.
Prometheus Biosciences Inc.
Axonics Modulation Technologies Inc.
Oncternal Therapeutics Inc.
GENOMIC
Galecto Inc.
AngioDynamics Inc.
Elanco Animal Health Incorporated

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace ...

Added to Collection on: 2021-03-23 15:33:45

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
COVID-19 drug development
Casirivimab/imdevimab
NASDAQ
Gilead Sciences
BioCryst Pharmaceuticals
Regeneron Pharmaceuticals
Antisense therapy
Novo Nordisk
Protagonist Therapeutics Inc
Oramed Pharmaceuticals Inc.
Nuvation Bio Inc.
Radius Health Inc.
the Endocrine Society
Organogenesis Holdings Inc.
Bristol
Adagene Inc.
Sesen Bio Inc.
TreatmentChiasma, Inc.
Odonate Therapeutics Inc
Finch Therapeutics Group Inc.
Sierra Oncology Inc
MacroGenics Inc.
BioCryst Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc.
Acceleron Pharma Inc.
Harmony Biosciences Holdings Inc.
Reviva Pharmaceuticals Holdings Inc.
Seneca Biopharma Inc.
Aclaris Therapeutics Inc.
Theratechnologies Inc.
SI-BONE Inc.
Instil Bio Inc.
CTI BioPharma Corp

Click the tags to see associated articles and topics

View Article Details
Analysts Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.26 EPS

Added to Collection on: 2021-04-18 02:15:00

Tags for this article:

Financial ratios
Finance
Money
BioCryst Pharmaceuticals
Economy
Fundamental analysis
Corporate finance
Price?earnings ratio
Earnings per share
Short
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
$12.80 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) This Quarter

Added to Collection on: 2021-04-18 02:20:35

Tags for this article:

Finance
Money
Economy
BioCryst Pharmaceuticals
Valuation
Stock market
Securities research
Short
Price?earnings ratio
Financial analyst
Stock
BioCryst Pharmaceuticals Inc.
Zacks

Click the tags to see associated articles and topics

View Article Details
Zacks: Brokerages Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Will Announce ...

Added to Collection on: 2021-05-05 05:26:15

Tags for this article:

BioCryst Pharmaceuticals
Life Sciences
Peramivir
Health care
Pharmaceutical industry in China
Biotechnology
BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals Inc.
Zacks

Click the tags to see associated articles and topics

View Article Details
BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) large institutional owners must be happy ...

Added to Collection on: 2025-02-01 13:54:17

Tags for this article:

Stock market
Institutional investors
BioCryst Pharmaceuticals
Alternative investment management companies
Equity securities
Private equity
Insider trading
Hedge fund
Stock
Dividend
BioCryst Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo